Fohlin, Helena, et al. “Breast Cancer Hormone Receptor Levels and Benefit from Adjuvant Tamoxifen in a Randomized Trial With Long-Term Follow-up”. Acta Oncologica, vol. 63, no. 1, July 2024, pp. 535-41, doi:10.2340/1651-226X.2024.40493.